Table 1.

Demographic and clinical characteristics of patients at baseline.

	Ubiquinol N = 61	Placebo N = 68
Age
Mean (SD)	59.8 (8.5)	62.0 (8.3)
Median (min, max)	61.0 (43, 79)	61.5 (42, 78)
Sex
Number (male/female)	44/17 (72.1%/27.9%)	38/30 (55.9%/44.1%)
UMSARS part 2 score
Mean (SD)	23.2 (8.7)	23.3 (7.9)
V393A in COQ2
Number of carriers	10 (16.4%)	11 (16.2%)
Subtype
Number of MSA-C	48 (78.7%)	51 (75.0%)
Number of MSA-P	13 (21.3%)	17 (25.0%)
Body height (cm)
Mean (SD)	163.4 (9.2)	161.3 (9.8)
Body weight (kg)
Mean (SD)	65.5 (13.1)	61.6 (12.1)
Body mass index
Mean (SD)	24.5 (4.2)	23.6 (3.2)
Past medical history
Present	30 (49.2%)	40 (58.8%)
Absent	31 (50.8%)	28 (41.2%)
Comorbidity
Present	59 (96.7%)	61 (89.7%)
Absent	2 (3.3%)	7 (10.3%)
Disease duration (year)
Mean (SD)	3.7 (1.8)	3.8 (1.7)
Median (min, max)	3.0 (1, 10)	3.0 (1, 10)